Online Mendelian Inheritance in Man (OMIM) (original) (raw)

  1. Adams, D., Algalarrondo, V., Echaniz-Laguna, A.Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatments. Blood 142: 1600-1612, 2023. [PubMed: 37624911] [Full Text: https://doi.org/10.1182/blood.2023019884\]
  2. Adams, D., Koike, H., Slama, M., Coelho, T.Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat. Rev. Neurol. 15: 387-404, 2019. [PubMed: 31209302] [Full Text: https://doi.org/10.1038/s41582-019-0210-4\]
  3. Altland, K., Winter, P.Potential treatment of transthyretin-type amyloidoses by sulfite. Neurogenetics 2: 183-188, 1999. [PubMed: 10541593] [Full Text: https://doi.org/10.1007/s100480050081\]
  4. Ando, Y., Nakamura, M., Araki, S.Transthyretin-related familial amyloidotic polyneuropathy. Arch. Neurol. 62: 1057-1062, 2005. [PubMed: 16009758] [Full Text: https://doi.org/10.1001/archneur.62.7.1057\]
  5. Ando, Y., Tanaka, Y., Nakazato, M., Ericzon, B.-G., Yamashita, T., Tashima, K., Sakashita, N., Suga, M., Uchino, M., Ando, M.Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation. Biochem. Biophys. Res. Commun. 211: 354-358, 1995. [PubMed: 7794243] [Full Text: https://doi.org/10.1006/bbrc.1995.1820\]
  6. Ando, Y., Yamashita, T., Tanaka, Y., Tashima, K., Yonehara, T., Gotoh, T., Sakashita, N., Uchino, M., Ando, M.Role of nitric oxide in the peripheral vessels of patients with familial amyloidotic polyneuropathy (FAP) type I. J. Auton. Nerv. Syst. 50: 79-85, 1994. [PubMed: 7844317] [Full Text: https://doi.org/10.1016/0165-1838(94)90125-2\]
  7. Andrade, C.A peculiar form of peripheral neuropathy: familial atypical generalised amyloidosis with special involvement of peripheral nerves. Brain 75: 408-427, 1952. [PubMed: 12978172] [Full Text: https://doi.org/10.1093/brain/75.3.408\]
  8. Benson, M. D., Cohen, A. S.Generalized amyloid in a family of Swedish origin: a study of 426 family members in 7 generations of a new kinship with neuropathy, nephropathy and central nervous system involvement. Ann. Intern. Med. 86: 419-424, 1977. [PubMed: 192115] [Full Text: https://doi.org/10.7326/0003-4819-86-4-419\]
  9. Benson, M. D., Waddington-Cruz, M., Berk, J. L., Polydefkis, M., Dyck, P. J., Wang, A. K., Plante-Bordeneuve, V., Barroso, F. A., Merlini, G., Obici, L., Scheinberg, M., Brannagan, T. H., III, and 23 others.Inotersen treatment for patients with hereditary transthyretin amyloidosis. New Eng. J. Med. 379: 22-31, 2018. [PubMed: 29972757] [Full Text: https://doi.org/10.1056/NEJMoa1716793\]
  10. Benson, M. D.Characterization of an amyloid fibril protein in heredofamilial amyloidosis. (Abstract) Clin. Res. 28: 340A, 1980.
  11. Benson, M. D.Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin. J. Clin. Invest. 67: 1035-1041, 1981. [PubMed: 6782125] [Full Text: https://doi.org/10.1172/jci110114\]
  12. Benson, M. D.Personal Communication. Indianapolis, Ind. 12/22/1986.
  13. Benson, M. D.Inherited amyloidosis. J. Med. Genet. 28: 73-78, 1991. [PubMed: 1848299] [Full Text: https://doi.org/10.1136/jmg.28.2.73\]
  14. Benson, M. D.Amyloidosis. In: Scriver, C. R.; Beaudet, A. L.; Sly, W. S.; Valle, D. (eds.): The Metabolic and Molecular Bases of Inherited Disease. Vol. 4. (8th ed.) New York: McGraw-Hill (pub.) 2001. Pp. 5345-5378.
  15. Blevins, G., Macaulay, R., Harder, S., Fladeland, D., Yamashita, T., Yazaki, M., Hamidi Asl, K., Benson, M. D., Donat, J. R.Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant tyr69his. Neurology 60: 1625-1630, 2003. [PubMed: 12771253] [Full Text: https://doi.org/10.1212/01.wnl.0000065901.18353.ab\]
  16. Coelho, T., Adams, D., Silva, A., Lozeron, P., Hawkins, P. N., Mant, T., Perez, J., Chiesa, J., Warrington, S., Tranter, E., Munisamy, M., Falzone, R., and 19 others.Safety and efficacy of RNAi therapy for transthyretin amyloidosis. New Eng. J. Med. 369: 819-829, 2013. [PubMed: 23984729] [Full Text: https://doi.org/10.1056/NEJMoa1208760\]
  17. Coelho, T., Sousa, A., Lourenco, E., Ramalheira, J.A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J. Med. Genet. 31: 293-299, 1994. [PubMed: 8071954] [Full Text: https://doi.org/10.1136/jmg.31.4.293\]
  18. Coimbra, A., Andrade, C.Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. I. Interstitial changes. Brain 94: 199-206, 1971. [PubMed: 4328329] [Full Text: https://doi.org/10.1093/brain/94.2.199\]
  19. Coimbra, A., Andrade, C.Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. II. Nerve fiber changes. Brain 94: 207-212, 1971. [PubMed: 4328330] [Full Text: https://doi.org/10.1093/brain/94.2.207\]
  20. Cornwell, G. G., Westermark, P., Natvig, J. B., Murdock, W.Senile cardiac amyloid: evidence that fibrils contain a protein immunologically related to prealbumin. Immunology 44: 447-452, 1981. [PubMed: 7033114]
  21. Costa, P. P., Figueira, A. S., Bravo, F. R.Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc. Nat. Acad. Sci. 75: 4499-4503, 1978. [PubMed: 279930] [Full Text: https://doi.org/10.1073/pnas.75.9.4499\]
  22. Coutinho, P., Sequeiros, J.Familial amyloidotic polyneuropathy and Machado-Joseph disease: two rare autosomal dominant neurologic diseases in the same family: the 'Iiyama type' of FAP? (Abstract) Am. J. Hum. Genet. 45 (suppl.): A43, 1989.
  23. Dalakas, M. C., Engel, W. K.Amyloid in hereditary amyloid polyneuropathy is related to prealbumin. Arch. Neurol. 38: 420-422, 1981. [PubMed: 7018469] [Full Text: https://doi.org/10.1001/archneur.1981.00510070054008\]
  24. De Bruyn, R. S., Stern, R. O.A case of the progressive hypertrophic polyneuritis of Dejerine and Sottas, with pathological examination. Brain 52: 84-107, 1929.
  25. De Navasquez, S., Treble, H. A.A case of primary generalized amyloid disease with involvement of the nerves. Brain 61: 116-128, 1938.
  26. Dowell, J. D., Fleck, J. D., Vakili, S. T., Benson, M. D.Familial oculoleptomeningeal amyloidosis associated with primary angiitis of the CNS. Neurology 68: 77-78, 2007. [PubMed: 17200500] [Full Text: https://doi.org/10.1212/01.wnl.0000250343.34110.79\]
  27. Drugge, U., Andersson, R., Chizari, F., Danielsson, M., Holmgren, G., Sandgren, O., Sousa, A.Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J. Med. Genet. 30: 388-392, 1993. [PubMed: 8100581] [Full Text: https://doi.org/10.1136/jmg.30.5.388\]
  28. Ducla-Soares, J., Alves, M. M., Carvalho, M., Povoa, P., Conceicao, I., Sales Luis, M. L.Correlation between clinical, electromyographic and dysautonomic evolution of familial amyloidotic polyneuropathy of the Portuguese type. Acta Neurol. Scand. 90: 266-269, 1994. [PubMed: 7839813] [Full Text: https://doi.org/10.1111/j.1600-0404.1994.tb02719.x\]
  29. Furuya, H., Yoshioka, K., Sasaki, H., Sakaki, Y., Nakazato, M., Matsuo, H., Nakadai, A., Ikeda, S., Yanagisawa, N.Molecular analysis of a variant type of familial amyloidotic polyneuropathy showing cerebellar ataxia and pyramidal tract signs. J. Clin. Invest. 80: 1706-1711, 1987. [PubMed: 3479441] [Full Text: https://doi.org/10.1172/JCI113261\]
  30. Garzuly, F., Vidal, R., Wisniewski, T., Brittig, F., Budka, H.Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR asp18gly). Neurology 47: 1562-1567, 1996. Note: Erratum: Neurology 48: 1143 only, 1997. [PubMed: 8960746] [Full Text: https://doi.org/10.1212/wnl.47.6.1562\]
  31. Glenner, G. G., Eanes, E. D., Bladen, H. A., Linke, R. P., Termine, J. D.Beta-pleated sheets fibrils: a comparison of native amyloid with synthetic protein fibrils. J. Histochem. Cytochem. 22: 1141-1158, 1974. [PubMed: 4443557] [Full Text: https://doi.org/10.1177/22.12.1141\]
  32. Glenner, G. G., Terry, W., Harada, M., Isersky, C., Page, D.Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science 172: 1150-1151, 1971. [PubMed: 4102463] [Full Text: https://doi.org/10.1126/science.172.3988.1150\]
  33. Glenner, G. G., Wong, C. W.Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120: 885-890, 1984. [PubMed: 6375662] [Full Text: https://doi.org/10.1016/s0006-291x(84)80190-4\]
  34. Goren, H., Steinberg, M. C., Farboody, G. H.Familial oculoleptomeningeal amyloidosis. Brain 103: 473-495, 1980. [PubMed: 7417777] [Full Text: https://doi.org/10.1093/brain/103.3.473\]
  35. Gorevic, P. D., Pras, M., Wright, J. R., Frangione, B.'Senile' cardiac amyloidosis: isolation of fibrils and immunohistological identity with heredofamilial neuropathic amyloid due to tissue deposition of prealbumin. (Abstract) Clin. Res. 30: 349A, 1982.
  36. Hagiwara, K., Ochi, H., Suzuki, S., Shimizu, Y., Tokuda, T., Murai, H., Shigeto, H., Ohyagi, Y., Iwata, M., Iwaki, T., Kira, J.Highly selective leptomeningeal amyloidosis with transthyretin variant Ala25Thr. Neurology 72: 1358-1360, 2009. [PubMed: 19365058] [Full Text: https://doi.org/10.1212/WNL.0b013e3181a0fe74\]
  37. Hamburg, A.Unusual cause of vitreous opacities: primary familial amyloidosis. Ophthalmologica 162: 173-177, 1971. [PubMed: 5089749] [Full Text: https://doi.org/10.1159/000306260\]
  38. Herrick, M. K., DeBruyne, K., Horoupian, D. S., Skare, J., Vanefsky, M. A., Ong, T.Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 47: 988-992, 1996. [PubMed: 8857732] [Full Text: https://doi.org/10.1212/wnl.47.4.988\]
  39. Holmgren, G., Costa, P. M. P., Andersson, C., Asplund, K., Steen, L., Beckman, L., Nylander, P.-O., Teixeira, A., Saraiva, M. J. M., Costa, P. P.Geographical distribution of TTR met-30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J. Med. Genet. 31: 351-354, 1994. [PubMed: 8064809] [Full Text: https://doi.org/10.1136/jmg.31.5.351\]
  40. Holmgren, G., Ericzon, B.-G., Groth, C.-G., Steen, L., Suhr, O., Andersen, O., Wallin, B. G., Seymour, A., Richardson, S., Hawkins, P. N., Pepys, M. B.Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341: 1113-1116, 1993. [PubMed: 8097803] [Full Text: https://doi.org/10.1016/0140-6736(93)93127-m\]
  41. Holmgren, G., Haettner, E., Nordenson, I., Sandgren, O., Steen, L., Lundgren, E.Homozygosity for the transthyretin-met(30)-gene in two Swedish sibs with familial amyloidotic polyneuropathy. Clin. Genet. 34: 333-338, 1988. [PubMed: 3229002] [Full Text: https://doi.org/10.1111/j.1399-0004.1988.tb02887.x\]
  42. Holmgren, G., Steen, L., Ekstedt, J., Groth, C.-G., Ericzon, B.-G., Eriksson, S., Andersen, O., Karlberg, I., Norden, G., Nakazato, M., Hawkins, P., Richardson, S., Pepys, M.Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin. Genet. 40: 242-246, 1991. [PubMed: 1685359] [Full Text: https://doi.org/10.1111/j.1399-0004.1991.tb03085.x\]
  43. Hund, E., Linke, R. P., Willig, M. D., Grau, A.Transthyretin-associated neuropathic amyloidosis: pathogenesis and treatment. Neurology 56: 431-435, 2001. [PubMed: 11261421] [Full Text: https://doi.org/10.1212/wnl.56.4.431\]
  44. Ikeda, S., Nakazato, M., Ando, Y., Sobue, G.Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 58: 1001-1007, 2002. [PubMed: 11940682] [Full Text: https://doi.org/10.1212/wnl.58.7.1001\]
  45. Ikeda, S., Yanagisawa, N., Hanyu, N., Furihata, K., Kobayashi, T.Coexistence of type I familial amyloid polyneuropathy and spinocerebellar ataxia type 1: clinical and genetic studies of a Japanese family. J. Neurol. Neurosurg. Psychiat. 60: 586-598, 1996. [PubMed: 8778271] [Full Text: https://doi.org/10.1136/jnnp.60.5.586-a\]
  46. Ikeda, S.-I., Hanyu, N., Hongo, M., Yoshioka, J., Oguchi, H., Yanagisawa, N., Kobayashi, T., Tsukagoshi, H., Ito, N., Yokota, T.Hereditary generalized amyloidosis with polyneuropathy: clinicopathological study of 65 Japanese patients. Brain 110: 315-337, 1987. [PubMed: 3032328] [Full Text: https://doi.org/10.1093/brain/110.2.315\]
  47. Jacobson, D. R., McFarlin, D. E., Kane, I., Buxbaum, J. N.Transthyretin pro-55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum. Genet. 89: 353-356, 1992. [PubMed: 1351039] [Full Text: https://doi.org/10.1007/BF00220559\]
  48. Jacobson, D. R., Pastore, R. D., Yaghoubian, R., Kane, I., Gallo, G., Buck, F. S., Buxbaum, J. N.Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in Black Americans. New Eng. J. Med. 336: 466-473, 1997. [PubMed: 9017939] [Full Text: https://doi.org/10.1056/NEJM199702133360703\]
  49. Kaufman, H. E., Thomas, L. B.Vitreous opacities diagnostic of familial primary amyloidosis. New Eng. J. Med. 261: 1267-1271, 1959. [PubMed: 14404854] [Full Text: https://doi.org/10.1056/NEJM195912172612503\]
  50. Kaufman, H. E.Primary familial amyloidosis. AMA Arch. Ophthal. 60: 1036-1043, 1958. [PubMed: 13593935] [Full Text: https://doi.org/10.1001/archopht.1958.00940081056009\]
  51. Koike, H., Misu, K., Sugiura, M., Iijima, M., Mori, K., Yamamoto, M., Hattori, N., Mukai, E., Ando, Y., Ikeda, S., Sobue, G.Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 63: 129-138, 2004. [PubMed: 15249622] [Full Text: https://doi.org/10.1212/01.wnl.0000132966.36437.12\]
  52. Koo, E. H., Lansbury, P. T., Jr., Kelly, J. W.Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Nat. Acad. Sci. 96: 9989-9990, 1999. [PubMed: 10468546] [Full Text: https://doi.org/10.1073/pnas.96.18.9989\]
  53. Kyle, R. A.Amyloidosis: a convoluted story. Brit. J. Haemat. 114: 529-538, 2001. [PubMed: 11552976] [Full Text: https://doi.org/10.1046/j.1365-2141.2001.02999.x\]
  54. Libbey, C. A., Rubinow, A., Shirahama, T., Deal, C., Cohen, A. S.Familial amyloid polyneuropathy: demonstration of prealbumin in a kinship of German/English ancestry with onset in the seventh decade. Am. J. Med. 76: 18-24, 1984. [PubMed: 6691355] [Full Text: https://doi.org/10.1016/0002-9343(84)90739-3\]
  55. Liu, Y.-T., Lee, Y.-C., Yang, C.-C., Chen, M.-L., Lin, K.-P.Transthyretin Ala97Ser in Chinese-Taiwanese patients with familial amyloid polyneuropathy: genetic studies and phenotype expression. J. Neurol. Sci. 267: 91-99, 2008. [PubMed: 18022643] [Full Text: https://doi.org/10.1016/j.jns.2007.10.011\]
  56. Mahloudji, M., Teasdall, R. D., Adamkiewicz, J. J., Hartmann, W. H., Lambird, P. A., McKusick, V. A.The genetic amyloidoses with particular reference to hereditary neuropathic amyloidosis, type II (Indiana or Rukavina type). Medicine 48: 1-37, 1969. [PubMed: 4884226]
  57. Munsat, T. L., Poussaint, A. F.Clinical manifestations and diagnosis of amyloid polyneuropathy: report of three cases. Neurology 12: 413-422, 1962. [PubMed: 14477245] [Full Text: https://doi.org/10.1212/wnl.12.6.413\]
  58. Okayama, M., Goto, I., Ogata, J., Omae, T., Yoshida, I., Inomata, H.Primary amyloidosis with familial vitreous opacities: an unusual case and family. Arch. Intern. Med. 138: 105-111, 1978. [PubMed: 202208]
  59. Petersen, R. B., Goren, H., Cohen, M., Richardson, S. L., Tresser, N., Lynn, A., Gali, M., Estes, M., Gambetti, P.Transthyretin amyloidosis: a new mutation associated with dementia. Ann. Neurol. 41: 307-313, 1997. [PubMed: 9066351] [Full Text: https://doi.org/10.1002/ana.410410305\]
  60. Ray, S. S., Lansbury, P. T., Jr.A possible therapeutic target for Lou Gehrig's disease. (Commentary) Proc. Nat. Acad. Sci. 101: 5701-5702, 2004. [PubMed: 15079068] [Full Text: https://doi.org/10.1073/pnas.0401934101\]
  61. Reixach, N., Deechongkit, S., Jiang, X., Kelly, J. W., Buxbaum, J. N.Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc. Nat. Acad. Sci. 101: 2817-2822, 2004. [PubMed: 14981241] [Full Text: https://doi.org/10.1073/pnas.0400062101\]
  62. Sandgren, O., Drugge, U., Holmgren, G., Sousa, A.Vitreous involvement in familial amyloidotic neuropathy: a genealogical and genetic study. Clin. Genet. 40: 452-460, 1991. [PubMed: 1685700] [Full Text: https://doi.org/10.1111/j.1399-0004.1991.tb03117.x\]
  63. Saraiva, M. J. M., Birken, S., Costa, P. P., Goodman, D. S.Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type: definition of molecular abnormality in transthyretin (prealbumin). J. Clin. Invest. 74: 104-119, 1984. [PubMed: 6736244] [Full Text: https://doi.org/10.1172/JCI111390\]
  64. Saraiva, M. J. M.Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum. Mutat. 17: 493-503, 2001. [PubMed: 11385707] [Full Text: https://doi.org/10.1002/humu.1132\]
  65. Saraiva, M. J. M.Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies. Expert Rev. Molec. Med. 4: 1-11, 2002. Note: Electronic Article. [PubMed: 14987380] [Full Text: https://doi.org/10.1017/S1462399402004647\]
  66. Sekijima, Y., Wiseman, R. L., Matteson, J., Hammarstrom, P., Miller, S. R., Sawkar, A. R., Balch, W. E., Kelly, J. W.The biological and chemical basis for tissue-selective amyloid disease. Cell 121: 73-85, 2005. [PubMed: 15820680] [Full Text: https://doi.org/10.1016/j.cell.2005.01.018\]
  67. Sequeiros, J., Saraiva, M. J. M.Onset in the seventh decade and lack of symptoms in heterozygotes for the TTR (met30) mutation in hereditary amyloid neuropathy: type I (Portuguese, Andrade). Am. J. Med. Genet. 27: 345-357, 1987. [PubMed: 3037905] [Full Text: https://doi.org/10.1002/ajmg.1320270213\]
  68. Sequeiros, J.Personal Communication. Baltimore, Md. 2/1984.
  69. Sipe, J. D.In memoriam: George G. Glenner, M.D. (1927-1995). Int. J. Exp. Clin. Invest. 2: 149, 1995.
  70. Sousa, L., Coelho, T., Taipa, R.CNS involvement in hereditary transthyretin amyloidosis. Neurology 97: 1111-1119, 2021. [PubMed: 34663645] [Full Text: https://doi.org/10.1212/WNL.0000000000012965\]
  71. Tanaka, M., Hirai, S., Matsubara, E., Okamoto, K., Morimatsu, M., Nakazato, M.Familial amyloidotic polyneuropathy without familial occurrence: carrier detection by the radioimmunoassay of variant transthyretin. J. Neurol. Neurosurg. Psychiat. 51: 576-578, 1988. [PubMed: 3379433] [Full Text: https://doi.org/10.1136/jnnp.51.4.576\]
  72. Uemichi, T., Uitti, R. J., Koeppen, A. H., Donat, J. R., Benson, M. D.Oculoleptomeningeal amyloidosis associated with a new transthyretin variant ser64. Arch. Neurol. 56: 1152-1155, 1999. [PubMed: 10488818] [Full Text: https://doi.org/10.1001/archneur.56.9.1152\]
  73. Ueno, S., Nakamura, Y., Takahashi, M., Tarui, S., Sasaki, H.'Nonprealbumin-related' familial amyloid polyneuropathy. Neurology 38: 333-334, 1988. [PubMed: 2829057] [Full Text: https://doi.org/10.1212/wnl.38.2.333\]
  74. Uitti, R. J., Donat, J. R., Rozdilsky, B., Schneider, R. J., Koeppen, A. H.Familial oculoleptomeningeal amyloidosis: report of a new family with unusual features. Arch. Neurol. 45: 1118-1122, 1988. [PubMed: 3178532] [Full Text: https://doi.org/10.1001/archneur.1988.00520340072015\]
  75. Vidal, R., Garzuly, F., Budka, H., Lalowski, M., Linke, R. P., Brittig, F., Frangione, B., Wisniewski, T.Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTR D18G). Am. J. Path. 148: 361-366, 1996. [PubMed: 8579098]
  76. Westermark, P., Sletten, K., Johansson, B., Cornwell, G. G., III.Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Nat. Acad. Sci. 87: 2843-2845, 1990. [PubMed: 2320592] [Full Text: https://doi.org/10.1073/pnas.87.7.2843\]
  77. Wong, V. G., McFarlin, D. E.Primary familial amyloidosis. Arch. Ophthal. 78: 208-213, 1967. [PubMed: 4952599] [Full Text: https://doi.org/10.1001/archopht.1967.00980030210015\]
  78. Yamada, M., Tsukagoshi, H., Satoh, J., Ishiai, S., Nakazato, M., Furuya, H., Sasaki, H., Sakaki, Y., Yokota, T.'Sporadic' prealbumin-related amyloid polyneuropathy: report of two cases. J. Neurol. 235: 69-73, 1987. [PubMed: 2828557] [Full Text: https://doi.org/10.1007/BF00718012\]
  79. Yamashita, T., Ueda, M., Nomura, T., Okazaki, T., Okada, M., Tsuda, Y., Inoue, Y., Masuda, T., Misumi, Y., Takamatsu, K., Obayashi, K., Inomata, Y., Hibi, T., Ando, Y.Natural history and long-term effects of variant protein reduction in non-V30M ATTR amyloidosis. Neurology 93: 714-716, 2019. [PubMed: 31562191] [Full Text: https://doi.org/10.1212/WNL.0000000000008320\]
  80. Yang, N. C.-C., Lee, M.-J., Chao, C.-C., Chuang, Y.-T., Lin, W.-M., Chang, M.-F., Hsieh, P.-C., Kan, H.-W., Lin, Y.-H., Yang, C.-C., Chiu, M.-J., Liou, H.-H., Hsieh, S.-T.Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser. Neurology 75: 532-538, 2010. [PubMed: 20697105] [Full Text: https://doi.org/10.1212/WNL.0b013e3181ec7fda\]
  81. Yi, S., Takahashi, K., Naito, M., Tashiro, F., Wakasugi, S., Maeda, S., Shimada, K., Yamamura, K., Araki, S.Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (met30) gene: pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am. J. Path. 138: 403-412, 1991. [PubMed: 1992765]